Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - AU
$ 2.0
-14.5 %
$ 35.3 M
Market Cap
-1.74
P/E
CASH FLOW STATEMENT
-15.8 M
OPERATING CASH FLOW
-277 K
INVESTING CASH FLOW
0
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Incannex Healthcare Limited
| Net Income | -18.5 M |
| Depreciation & Amortization | 103 K |
| Capital Expenditures | -277 K |
| Stock-Based Compensation | 8.93 M |
| Change in Working Capital | -14.2 M |
| Others | -6.42 M |
| Free Cash Flow | -16.1 M |
Cash Flow
Millions
| Jun-2024 | Jun-2023 | Jun-2022 | Jun-2021 | Jun-2020 | Jun-2019 | Jun-2018 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | Jun-2012 | Jun-2011 | Jun-2010 | Jun-2009 | Jun-2008 | Jun-2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||||
| Net Income | (18.5) | (13.2) | (10.3) | (8.5) | (4.7) | 0 | 0 | 0 | (0.8) | (2.5) | (12.0) | (12.0) | (3.1) | (4.7) | 2.5 | (3.9) | (1.1) | (1.1) |
| Depreciation & Amortization | 0.1 | 86.7 K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.5 K | 39.5 K | 28.7 K | 41.3 K | 42.3 K | 51.3 K | 56.1 K | 46.8 K | 10.9 K |
| Deferred Income Tax | 0 | 1.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 8.9 | 3.2 | 1.0 | 0.5 | 0.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 7.8 | 4.25 K | (0.4) | 2.9 | 0.6 | 0 | 0 | 0 | 0.8 | 2.5 | 11.9 | 12.0 | 3.1 | 4.7 | (2.6) | 3.8 | 1.1 | 1.1 |
| Change in Working Capital | (14.2) | 0.5 | 0.8 | 4.33 K | (0.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Operations | (15.8) | (10.6) | (8.8) | (5.2) | (3.9) | 0 | 0 | 0 | (0.8) | (2.5) | (11.9) | (12.0) | (3.1) | (4.7) | 2.6 | (3.8) | (1.1) | (1.1) |
| INVESTING CASH FLOW | ||||||||||||||||||
| Capital Expenditures | (0.3) | (0.3) | 0 | 0 | 0 | 24.4 K | 47.6 K | 50.1 K | (0.1) | 3.48 K | 19.2 K | (0.2) | (1.1) | (2.2) | 6.05 K | (0.3) | 65.5 K | 68.5 K |
| Other Items | 0 | 0 | 29.3 K | 22 K | 8.93 K | 0 | 0 | 3.1 | 1.4 | 16 K | 0 | 1.2 K | 30 K | (1.5) | 0 | 0 | (1.5) | 0 |
| Cash From Investing Activities | (0.3) | (0.3) | 29.3 K | 22 K | 8.93 K | 24.4 K | 47.6 K | 3.0 | 1.3 | 12.5 K | 19.2 K | (0.2) | (1.1) | (3.7) | 6.05 K | (0.3) | (1.6) | 68.5 K |
| FINANCING CASH FLOW | ||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0 | (0.2) | (0.5) | (0.4) | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 36.2 K | 0 | 0 | 44.7 K | 94.5 K | (0.1) | 0.2 | 0 | 0 | (0.5) | 0.5 | 0 | 0.2 | 32.1 K | 0.7 | 35.6 K | 5.32 K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1.4) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 4.1 | 28.3 | 12.4 | 0.204 | 0.24 | 0.387 | 39.8 K | (0.6) | 84.2 K | 29.3 K | (0.2) | (0.5) | 0.5 | 0.2 | 0 | 0.15 | 0.0857 |
| Cash From Financing Activities | 0 | 8.1 | 41.2 | 9.3 | 5.1 | 2.0 | 2.6 | 0.2 | (0.6) | 0.9 | (0.5) | 4.5 | 7.5 | 6.1 | 3.2 | 1.5 | 77.2 K | 5.3 |
| CHANGE IN CASH | ||||||||||||||||||
| Net Change In Cash | (16.3) | (2.7) | 19.5 | 4.1 | 2.4 | (0.1) | (0.3) | 0.5 | 73.6 K | (0.2) | (0.1) | 39.5 K | (0.2) | (0.8) | 1.5 | (1.1) | (3.8) | 4.8 |
| FREE CASH FLOW | ||||||||||||||||||
| Free Cash Flow | (16.1) | (10.9) | (8.8) | (5.2) | (3.9) | 24.4 K | 47.6 K | 50.1 K | (0.9) | (2.5) | (11.9) | (12.2) | (4.2) | (6.9) | 2.6 | (4.1) | (1.1) | (1.1) |